T1	Outcomes 9 24	bioavailability
T2	Outcomes 231 272	risk of age-related macular degeneration.
T3	Outcomes 423 438	bioavailability
T4	Outcomes 485 500	bioavailability
T5	Outcomes 549 575	zeaxanthin bioavailability
T6	Outcomes 1148 1172	Zeaxanthin concentration
T7	Outcomes 1248 1253	HPLC.
T8	Outcomes 1274 1324	triacylglycerol-rich lipoprotein zeaxanthin peaked
T9	Outcomes 1369 1395	Zeaxanthin bioavailability
T10	Outcomes 1485 1510	Mean area under the curve
T11	Outcomes 1777 1822	3-fold enhanced bioavailability of zeaxanthin